Bemarituzumab - CAS:1952272-74-0

致电 400-881-9290 或联系在线客服

您当前的位置：

Bemarituzumab (Synonyms:贝玛妥珠单抗)

目录号 : KM28166 CAS No. : 1952272-74-0 纯度 : 98%

Data Sheet 产品使用指南

Bemarituzumab is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research.

规格	价格	是否有货
1mg		In-stock
5mg	询价	In-stock
10mg	询价	In-stock

加入购物车大包装询价

Other Forms of Rapamycin:

Azasetron hydrochloride In-stock
Thyrotropic hormone In-stock
Fructose-arginine In-stock
Biotin-Elaidic acid In-stock
Insulin (swine) In-stock

KKL Med 的所有产品和服务仅用于科学研究，不能被用于人体，兽医，我们也不向个人提供产品和服务。

生物活性	Bemarituzumab is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research.
CAS号	1952272-74-0
中文名称	贝马里妥珠单抗
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Store at -20˚C